VISTN — Vistin Pharma ASA Income Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedSmall CapNeutral

Annual income statement for Vistin Pharma ASA, fiscal year end - December 31st, NOK millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	—	—	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	276	288	435	429	452
Cost of Revenue
Gross Profit	180	150	259	279	301
Selling / General / Administrative Expenses
Depreciation and Amortization
Other Operating Expenses
Total Operating Expenses	243	294	367	344	360
Operating Profit	33.3	-6.09	68.6	85.3	92.4
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	32	-6.01	58.5	80.5	95.8
Provision for Income Taxes
Net Income After Taxes	24.9	-4.71	45.6	62.8	74.8
Net Income Before Extraordinary Items
Net Income	24.9	-4.71	45.6	62.8	74.8
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	24.9	-4.72	45.6	62.8	74.8
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.561	-0.106	1.03	1.42	1.69
Dividends per Share